Why Is Semaglutide Being Compounded
FDA hasnt approved it yet as we need more studies to explore its efficacy in humans
This could be considered in future therapies
It may help provide context for personalized treatment conversations but does not predict exact medication response
The search terms are glucagon-like peptide-1 receptor agonist (including exenatide, liraglutide, albiglutide, lixisenatide, semaglutide, dulaglutide, taspoglutide), sodium glucose cotransporter 2 inhibitor (including canagliflozin, empagliflozin, dapagliflozin, ipragliflozin, luseogliflozin, tofogliflozin, remogliflozin, sergliflozin, sotagliflozin, ertugliflozin) and type 2 diabetes mellitus